Peripheral spondyloarthritis: What have we learned?

Area of Science:

• Rheumatology
• Immunology
• Clinical Medicine

Background:

• Peripheral spondyloarthritis (pSpA) lacks clear definition compared to axial SpA and psoriatic arthritis.
• Clinical symptoms of pSpA are non-specific, biomarkers are scarce, and dedicated clinical trials are limited.
• Pathophysiological similarities exist between pSpA and psoriatic arthritis (PsA), complicating diagnosis.

Purpose of the Study:

• To provide a comprehensive review of the current understanding of pSpA.
• To summarize epidemiology, pathophysiology, clinical diagnosis, and classification criteria for pSpA.
• To discuss patient-reported outcomes, available therapies, and future research directions for pSpA.

Main Methods:

• Literature review of existing studies on peripheral spondyloarthritis.
• Synthesis of data on pSpA epidemiology, pathogenesis, and clinical presentation.
• Analysis of current diagnostic and classification criteria, therapies, and patient-reported outcomes.

Main Results:

• pSpA diagnosis is challenging due to overlapping symptoms with other conditions and absence of definitive diagnostic tests.
• Current understanding of pSpA pathophysiology is evolving, with links to psoriatic arthritis.
• Limited data exists on patient-reported outcomes and specific therapies for pSpA.

Conclusions:

• Further research is needed to establish clear diagnostic criteria and targeted therapies for pSpA.
• Improved understanding of pSpA pathophysiology may lead to better diagnostic and therapeutic strategies.
• Standardized patient-reported outcomes are crucial for evaluating treatment efficacy in pSpA.